Cargando…
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
Wilms tumour (WT) is the most common renal tumour in children. Most WT patients respond to chemotherapy, but subsets of tumours develop resistance to chemotherapeutic agents, which is a major obstacle in their successful treatment. Multidrug resistance transporters play a crucial role in the develop...
Autores principales: | Hontecillas-Prieto, Lourdes, Garcia-Dominguez, Daniel J., Vaca, Diego Pascual, Garcia-Mejias, Rosa, Marcilla, David, Ramirez-Villar, Gema L., Saez, Carmen, de Álava, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355255/ https://www.ncbi.nlm.nih.gov/pubmed/28061436 http://dx.doi.org/10.18632/oncotarget.14491 |
Ejemplares similares
-
Correction: Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
por: Hontecillas-Prieto, Lourdes, et al.
Publicado: (2017) -
HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients
por: Hontecillas-Prieto, Lourdes, et al.
Publicado: (2017) -
Wilms’ Tumor Blastemal Stem Cells Dedifferentiate to Propagate the Tumor Bulk
por: Shukrun, Rachel, et al.
Publicado: (2014) -
High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro
por: Wegert, Jenny, et al.
Publicado: (2019) -
Two Origins of Blastemal Progenitors Define Blastemal Regeneration of Zebrafish Lower Jaw
por: Wang, Xuelong, et al.
Publicado: (2012)